BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Galena Biopharma  

310 N. State Street, Suite 208

Lake Oswego   Oregon  97034  U.S.A.
Phone: 1-503-400-7636 Fax: 1-503-400-6611


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Galena Biopharma  (GALE) CEO Allegedly Fired Following Stock-Promotions Scandal, New CEO Named 8/21/2014 6:16:54 AM
Galena Biopharma  (GALE) Reports Second Quarter 2014 Results 8/11/2014 5:05:46 PM
Galena Biopharma  (GALE) Gives Sales Team Another Useless Product To Promote 7/23/2014 6:03:10 AM
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma  (GALE) For Zuplenz(R) Oral Soluble Film 7/22/2014 1:14:11 PM
Galena Biopharma  (GALE) Enters Into Definitive Agreement to License U.S. Rights for Zuplenz® (ondansetron) Oral Soluble Film 7/22/2014 9:23:29 AM
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Broad U.S. Patent For Neuvax™ (Nelipepimut-S) 7/1/2014 8:50:49 AM
Galena Biopharma  (GALE) To Present At The 9th Annual JMP Securities Healthcare Conference 6/19/2014 8:36:33 AM
Galena Biopharma  (GALE) Completes Enrollment In GALE-301 Phase 2a Clinical Trial In Ovarian And Endometrial Cancers 6/17/2014 8:55:47 AM
Galena Biopharma  (GALE) Presents GALE-301 Phase 1 Data At The American Society of Clinical Oncology 50th Annual Meeting 6/2/2014 9:35:36 AM
Galena Biopharma  (GALE) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/30/2014 9:04:32 AM
12345678910...